VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1482592
Sex: F
Age:
State:

Vax Date: 03/22/2021
Onset Date: 03/23/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Knee pain; Headache; Arm and Forehead Tingling; Room spinning; This is a spontaneous report received from a non-contactable consumer, the patient. A 57-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er2613), via an unspecified route of administration on 22Mar2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021, the patient experienced room spinning, knee pain, headache, arm and forehead tingling. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events room spinning, knee pain, headache, arm and forehead tingling were not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482593
Sex: F
Age:
State: FL

Vax Date: 03/21/2021
Onset Date: 03/22/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; vomiting; Headache; Tinnitus; Weakness; lassitude; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 21Mar2021 at 14:30 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to opiates (intolerance to opiates). The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021 at 00:30, the patient experienced nausea, vomiting that lasted for several hours, headache lasted until following morning, tinnitus, weakness and lassitude lasted approximately for 24 hours. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea, vomiting, headache, tinnitus, weakness and lassitude were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482594
Sex: F
Age:
State: RI

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable other healthcare professional, the patient. A 50-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via unspecified route of administration in the left arm on 19Mar2021 at 14:00 (at the age of 50-years-old), as a single dose for COVID-19 immunization. Medical history and concomitant medications were reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, the day after injection, the patient experienced, soreness in arm, headache and fatigue and one week and one day after injection the patient experienced migraine headache. The adverse events resulted in an emergency room visit or department urgent care visit and treatment was received for the adverse events. The clinical outcomes of soreness in arm, headache, fatigue and migraine were unknown, at this time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482595
Sex: M
Age:
State: WI

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 51-year-old, male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 30Mar2021 at 09:00 (age at vaccination 51-year-old) as single dose for COVID-19 immunization. Medical history included high blood pressure, sleep apnea and COVID-19. The patient had history of allergy to bone. Concomitant medications included losartan (MANUFACTURER UNKNOWN), meloxicam (MANUFACTURER UNKNOWN), advair inhaler (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. Prior to vaccination the patient was diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021 at 22:00, the patient experienced dizziness, fever (101.9), tiredness, nausea and ringing in ears. No therapeutic measures were taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event dizziness, fever, tiredness, nausea and ringing in ears were resolving. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LOSARTAN; MELOXICAM

Current Illness:

ID: 1482596
Sex: F
Age:
State:

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a non-contactable consumer (patient). A 24-year-old female patient received first dose of BNT162B2 via an unspecified route of administration, administered in arm left on 19Mar2021 13:30 (age at 24 years old, Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient had peanuts, shellfish, shrimp allergies. Medical history also included asthma, autoimmune issues. The patient was not diagnosed with COVID-19 prior to vaccination and the patient did not test for COVID-19 since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included loratadine (CLARITIN); Vitamin D nos (VITAMIN D); Vitamin B12 nos (VITAMIN B12). About 20 minutes after vaccination (19Mar2021 13:45), the patient experienced a loss of feeling in mouth and lips. This occurred intermittently over the next three days. Four days after the injection on 23Mar2021, the numbness spread to entire face and to extremities. The sensation was akin to getting an anesthetic like novocaine which was just starting to wear off. The events needed doctor or other healthcare professional office/clinic visit. Steroid (prednisone) was taken to reduce inflammation. Both events were not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: CLARITIN [LORATADINE]; VITAMIN D [VITAMIN D NOS]; VITAMIN B12 [VITAMIN B12 NOS]

Current Illness:

ID: 1482597
Sex: F
Age:
State: SC

Vax Date: 03/28/2021
Onset Date: 03/28/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen sore right arm; Metal taste; swollen sore right arm; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730), via an unspecified route of administration in the right arm on 28Mar2021 at 16:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had a history of allergy to black ants, cockroaches and had seasonal allergies. Concomitant medication included cetirizine hydrochloride (ZYRTEC) for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021 at 16:45, the patient experienced swollen sore right arm, and had metal taste which was like, she had a coin in her mouth that would not go away. She tried drinking lots of fluids, eating and mouth wash, which was not beneficial. Other than that, the patient felt fine. These events started about 30 minutes to an hour after the vaccination. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the events swollen sore right arm and metal taste was not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: zyrtec

Current Illness:

ID: 1482598
Sex: F
Age:
State: MO

Vax Date: 02/20/2021
Onset Date: 02/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Slight headache; trouble walking; Tired.; Body temperature; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6200,), via an unspecified route of administration in the left arm on 20Feb2021 at 09:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had allergies to medications, food, or other products (details unspecified). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EL9264), via an unspecified route of administration in the left arm on 30Jan2021 at 16:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, patient was not diagnosed with COVID-19. Since vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Feb2021 at 07:00, the patient experienced slight headache, temperature 100.4 (unit unspecified), trouble walking, effected both knees and tired. The events resulted in doctor or other healthcare professional office/clinic visit. However, no therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events slight headache, temperature 100.4 (unit unspecified), trouble walking, effected both knees and tired were recovering at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482599
Sex: F
Age:
State: AZ

Vax Date: 03/26/2021
Onset Date: 03/28/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dry heaves; Chills; Headache; This is a spontaneous report from a contactable consumer. A 66-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: E90955) via an unspecified route of administration in the left arm, on 26Mar2021 at 11:00 (at the age of 66-year-old), as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa (sulfonamide allergy). Concomitant medication was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 26Feb2021 at 11:30 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 28Mar2021 at 18:00, the patient experienced chills, dry heaves and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of chills, dry heaves and headache were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482600
Sex: F
Age:
State: PA

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache.; Muscle aches especiallyaround the injection site; Injection site feels warm or hot.; Body temperature changes from hot to freezing in seconds.; Tired; feeling unwell; feverish but no fever; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 02:15 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had history of allergy to codeine. Concomitant medications included paracetamol (TYLENOL), naproxen (MOTRIN), mepyramine maleate, mepyramine maleate, paracetamol (PAMPRIN), mefenamic acid (ADVIL) and melatonin (MANUFACTURER UNKNOWN) all for unknown indication on unknown dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021, at 12:00 the patient experienced headache, muscle aches especially around the injection site, warm or hot at Injection site, feverish but not fever, body temperature changes from hot to freezing in seconds, tired and overall feeling unwell. No therapeutic measures were taken for the events. The adverse events did not result in doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, muscle aches especially around the injection site, warm or hot at Injection site, feverish but not fever, body temperature changes from hot to freezing in seconds, tired and overall feeling unwell were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: MELATONIN; Advil; TYLENOL; PAMPRIN; Motrin

Current Illness:

ID: 1482601
Sex: F
Age:
State: FL

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body aches; High Fever; This is a spontaneous report from a contactable consumer. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown), via an unspecified route of administration in the left arm on 26Mar2021 at 08:30 (at the age of 56-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history reported. Concomitant medications included doxycycline (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. On 27Mar2021 at 12:00, the patient experienced body aches and high fever. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events body aches and high fever was recovered on an unknown date at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: DOXYCYCLINE

Current Illness:

ID: 1482602
Sex: F
Age:
State: CA

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt very week,; following day, I got fever,; headache,; bodyache; joint pain,; nauseas.; after 3 hrs receiving vaccine got extremly tired.; Very sleepy, slept into the following day.; This is a spontaneous report received from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number:ER8732), via an unspecified route of administration in the left arm on 26Mar2021 at 13:45 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Concomitant medications were reported as none. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 17:00, the patient experienced extremely tired, very sleepy, slept into the following day. On27Mar2021 patient experienced fever, headache, body ache, joint pain, nauseas, and on an unknown date felt very week and slept most of the day. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit. The patient took TYLENOL as treatment for the reported events. The clinical outcome of the events extreme fatigue, very sleepy, fever, headache, body ache, joint pain, nauseas and very weak was resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482603
Sex: F
Age:
State: NM

Vax Date: 03/04/2021
Onset Date: 03/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 61-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) on 04Mar2021 (at the age of 61-years-old) as a single dose for COVID-19 immunization and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, mitral valve prolapse (MVP) and osteoarthritis. The patient did not have allergies to medications, food, or other products. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021, after first vaccine the patient experienced cold sore - left side of tongue for a couple of days. On 25Mar2021 after Second vaccine, the patient experienced cold sore- right side of tongue for a couple of days. The adverse events did not result in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for the reported events. The clinical outcome of the events cold sore (after first vaccine) and after second vaccine was recovered on an unknown date in Mar2021. No follow-up attempts are needed; information about lot number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021357059 same patient/drug/event occurred in different place

Other Meds:

Current Illness:

ID: 1482604
Sex: F
Age:
State: TX

Vax Date: 03/23/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea all day; Very tired/unusually tired; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via unspecified route of administration in left arm on 23Mar2021 at 16:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis and hypertension. The patient was allergic to penicillin. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and irbesartan (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 26Mar2021 (day 3), the patient experienced very tired, unusually tired. On 31Mar2021 at 08:00 (day 9), the patient experienced nausea all day. The patient had not received treatment for the adverse events. The clinical outcome of the events very tired and nausea were resolving at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: IBUPROFEN; IRBESARTAN

Current Illness:

ID: 1482605
Sex: F
Age:
State: NJ

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sneezing often; very congested; This is a spontaneous report from a contactable consumer, the patient. A 30-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration, in the left arm on 28Mar2021 at 18:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medication which the patient received within 2 weeks of vaccination included birth control and steroid taken for asthma from an unknown date. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested for COVID-19, which included nasal swab test on 11Mar2021 and resulted negative. On 29Mar2021 at 20:00 (24 hours after vaccine), the patient experienced very congested and sneezing often but the patient was not sure if this is related to the shot. Treatment was not received for adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events congested and sneezing often were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482606
Sex: F
Age:
State: NY

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in arm I received vaccine. Arm felt sore for about 2 days.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via unspecified route of administration in the arm on 25Mar2021 at 11:00 (at the age of 44-years-old) as a single dose for Covid-19 immunisation. Medical history and concomitant medication was reported as no. The patient was allergic to peanuts. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination, the patient had not been tested for COVID-19.The patient experienced pain in vaccinated arm on 25Mar2021, and arm felt sore for about 2 days. The patient had not received any treatment for the reported event. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the pain in arm was resolved. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482607
Sex: F
Age:
State: OK

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizziness; achiness; Terrible headache; tiredness; swelling of lips, tongue; Itching all over; swelling of lips, tongue; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route administration in the left arm on 01Mar2021 at 14:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to penicillin, cephalosporins and many other medications. Concomitant medications included routine unspecified allergy medicine and vitamins (MANUFACTURER UNKNOWN), for unknown indications from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01Mar2021 at 14:00, the patient experienced terrible headache, achiness, tiredness and dizziness. On 01Mar2021, the patient experienced itching all over and swelling of lips, tongue which started roughly 7-8 minutes after injection. The patient was released after 30 minutes to go home and instructed to take diphenhydramine (BENADRYL). The patient had to use inhaler as well. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received treatment with diphenhydramine (BENADRYL) and unspecified inhaler for the events itching all over and swelling of lips, tongue. The patient did not receive any treatment for events terrible headache, achiness, tiredness and dizziness. The clinical outcomes of the events headache, ache, tiredness, itching all over, dizziness, swelling of tongue and swelling of lips were recovered on an unknown date in Mar2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482608
Sex: M
Age:
State: FL

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sudden strong dizzy feeling while walking/ light headed feeling; felt off; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the left arm on 30Mar2021 at 12:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included eszopiclone (LUNESTA) 3mg and cetirizine hydrochloride (ZYRTEC) as OTC, daily night time. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 20:30, the patient experienced sudden strong dizzy feeling while walking. It was reported that, the patient was cleared, felt off (feeling abnormal) and slightly light headed. Light headed feeling was persisting, slightly dizzy almost like the patient could become nauseous but not. Slightly dizzy was persisting. The adverse event did not result in doctor/other healthcare professional office or clinic visit/emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of event sudden strong dizzy feeling while walking/ light headed feeling was not resolved and felt off (feeling abnormal) was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LUNESTA; Zyrtec

Current Illness:

ID: 1482609
Sex: F
Age:
State: NC

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: annoying itchiness; skin hives with irregular shapes appearing on different location of body parts of skin at different times. Localized to left forehead, neck, both earlobes, back of trunk, both upper arm and both thigh areas; burning sensation of red spots/skin hives; This is a spontaneous report from a non-contactable consumer, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN 6207) via an unspecified route of administration in the left arm on 19Mar2021 at 12:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies or allergic rhinitis. Any allergies to medications, food, or other products were reported as unknown. The patient received fosamax (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and Calcium, Vitamin D supplements (MANUFACTURER UNKNOWN) within two weeks prior to vaccination. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 18:00, after 5:30 hours, the patient experienced burning sensation of red spots/skin hives and skin hives with irregular shapes appearing on different location of body parts of skin at different times. Localized to left forehead, neck, both earlobes, back of trunk, both upper arm and both thigh areas. Subsided after ingestion of anti-allergy medication; recurring intervals of the day throughout the week for 2 weeks. On 29Mar2021 patient had annoying itchiness at the time reporting. Therapeutic measures were taken as a result of hives, burning sensation and itching and included prednisone 10 mg orally after meals. The adverse events had resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of hives, burning sensation was not recovered and the clinical outcome of itching was unknown at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds: FOSAMAX; Calcium & Vit.Dsupplements

Current Illness:

ID: 1482610
Sex: F
Age:
State: FL

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rapid heart rate; Elevated blood pressure; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number; ER2613) via an unspecified route of administration on 27Mar2021 at 16:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included losartan potassium (MANUFACTURER UNKNOWN) from an unknown date and for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021 at 16:00, the patient experienced rapid heart rate and elevated blood pressure. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the events rapid heart rate and elevated blood pressure was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN POTASSIUM

Current Illness:

ID: 1482611
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chest pains; This is a spontaneous report from a contactable (patient). A female patient of an unspecified age received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Prior to taking the second dose of the Pfizer-BioNTech COVID-19 Vaccine, patient was having some chest pains and took Aspirin 30 minutes before the vaccine. Patient reported only to have a had a sore arm and felt a little unwell. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482612
Sex: F
Age:
State: TN

Vax Date: 03/28/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Took BP, was 85/65-stayed in that range for 2 hours- laid down.; extreme light-headedness; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 28Mar2021 at 14:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included spontaneous coronary artery dissection (SCAD), migraines, irritable bowel syndrome (IBS) and non-ST segment elevation myocardial infarction (N-STEMI). Concomitant medications included apixaban (ELIQUIS), rosuvastatin (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and montelukast (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 07Mar2021 at 15:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was reported that the patient was only on metoprolol as a preventive so as not have a second SCAD. The patient did not have hypertension and was on 50 mg two times a day. On 30Mar2021 at 18:45, after dinner, the patient had extreme light-headedness. The patient was not dehydrated and was not fasting. The patient's blood pressure (BP) was measured which stayed in the range 85/65 for 2 hours-laid down. The patient had never been hypotensive either. This happened 52 hours post second vaccine. On 31Mar2021 (reported as next day), she still felt moderately light headed, but BP was better, in 107/75 to113/85 range. The patient's body mass index (BMI) was 23.77 kg/m2. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event took BP, was 85/65-stayed in that range for 2 hours-laid down was resolving while that of extreme light-headedness was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: ELIQUIS; ROSUVASTATIN; METOPROLOL; Zyrtec; MONTELUKAST

Current Illness:

ID: 1482613
Sex: F
Age:
State: OH

Vax Date:
Onset Date: 03/15/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: unspecified route of administration on an unknown date (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer 10 years ago. The patient did not have any known allergies. Concomitant medications included levothyroxine sodium (SYNTHROID) and venlafaxine hydrochloride (EFFEXOR) from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021 at 16:00, the patient experienced shaky, nausea, diarrhea, couldn't walk, headache and fever. Therapeutic measures were taken as a result of the events included treatment with TYLENOL ,ADVIL, ZOFRON and IMODIUM. The clinical outcomes of the events shaky, nausea, diarrhea, couldn't walk, headache, fever were not recovered at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SYNTHROID; EFFEXOR

Current Illness:

ID: 1482614
Sex: M
Age:
State:

Vax Date: 03/23/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: developed shingles two days after 2nd dose of vaccine; This is a spontaneous report from a non-contactable consumer, the patient. A 38-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration on 23Mar2021(at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 03Mar2021(at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021, two days after second dose of vaccine, the patient developed shingles. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of shingles and included treatment with antiviral medication. The clinical outcome of the event shingles was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1482615
Sex: F
Age:
State: CA

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Cloudy vision; Lightheaded; Numbness in left arm and hand; Strange dreams; Constipation; Loss of appetite; Lack of interest in anything; Chills; Fatigue; Abdominal pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included coronary artery disease. Concomitant medications were not reported. The patient previously received metronidazole (FLAGYL) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 14:45, the patient experienced chills, fatigue, abdominal pain, lightheaded, headache, cloudy vision, numbness in left arm and hand, strange dreams, loss of appetite, constipation and lack of interest in anything that was going on from 8 days. The adverse events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent lab test on 26Mar2021 which included nasal swab test and the test result was negative. The patient did not receive any treatment for the events chills, fatigue, abdominal pain, lightheaded, headache, cloudy vision, numbness in left arm and hand, strange dreams, loss of appetite, constipation and lack of interest. The clinical outcomes of the events chills, fatigue, abdominal pain, lightheaded, headache, cloudy vision, numbness in left arm and hand, strange dreams, loss of appetite, constipation and lack of interest were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482616
Sex: M
Age:
State: TN

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: extreme dizziness after 6 hours and still have it; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er8727) via unspecified route of administration in the left arm on 26Mar2021 at 10:00 (at the age of 42-years-old) as a single dose for Covid-19 immunisation. The patient medical history and concomitant medication were not reported. The patient received any other vaccines within 4 weeks prior to the COVID vaccine was unknown at the time of reporting. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 17:00, 6 hours after vaccination, patient experienced extreme dizziness and still had it. The patient received dizziness pills for the adverse event. The event resulted in emergency room/department or urgent care visit. The clinical outcome of the event dizziness was not resolved at the time of reporting. No follow-up attempts are needed. No further information expected.

Other Meds:

Current Illness:

ID: 1482617
Sex: F
Age:
State: CA

Vax Date: 03/23/2021
Onset Date:
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A 41-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number and expiry date were not provided) via an unspecified route of administration on 23Mar2021 (at age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Patient had previously received first dose of bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number and expiry date were not provided) on 02Mar2021 (at age of 41-years-old) as a single dose for COVID-19 immunisation. On an unspecified date, patient has welts on the arms and neck. Treatment received was diphenhydramine hydrochloride (BENADRYL) but they won't go away, she had been taking 1 capsule 25 mg once a day and now going to take 2 capsules because getting more welts and was scratching her arms. In addition, one day she woke up with a swollen left eye and the next day, the right eye too. At the time of reporting, the outcome of events were unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482618
Sex: F
Age:
State: DE

Vax Date:
Onset Date:
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer. This 74-year-old female consumer reported. A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), Dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. The patient previously took advil pain patches, Aleve, and Salonpas pain patches for bad back and bad knees. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. On an unspecified date, the patient experienced pain in her joints and muscle, feeling achy, feeling like was getting a cold with sneezing and coughing that lasted a day, and feeling sleepy for 2 days but she was over that. She was given the vaccination, she stated they put the needle in way top of my shoulder where the bone was. She wanted to know how long her side effects were expected to last. That morning she heard on Good Morning America that the Pfizer BioNTech COVID-19 vaccine was good for up to 6 months. She understood that she would not have any of the protection against catching COVID-19 after 6 months and wanted to know what happened after the 6 months were over. She was concerned that in 6 months she would have to take another dose of the vaccine. She stated that when her daughter received her vaccination, her card had an expiration date written on it. Outcome of the events pain in her joints and muscle, feeling achy, feeling like was getting a cold with sneezing and coughing that lasted a day was reported as recovered on an unspecified date. Outcome of the events feeling sleepy for 2 days and given the vaccination, she stated they put the needle in way top of my shoulder where the bone was, was reported as unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482619
Sex: F
Age:
State: CT

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955) via an unspecified route of administration in left arm on 31Mar2021 at 09:30 (at the age of 30-years-old) as a single dose for COVID-19 immunization. Medical history included sulfonamide allergy. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL3247) via an unspecified route of administration in left arm on 10Mar2021 at 11:15 (at the age of 30-years-old) as a single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not been diagnosed with COVID-19 prior to the vaccination. Since vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 23:00, the patient experienced headache. No therapeutic measures were taken as a result of the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event headache was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482620
Sex: F
Age:
State: CA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in Arm Left on an unknown date in Mar2021 (Batch/Lot Number: ER2613) as single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included Hepatitis A vaccine for immunization on an unspecified date (after 2 of them, I never had antibodies either, I didn't check after the third one). Patient stated received the first dose of Pfizer covid vaccine about 12 days ago, shortly after she had tingling in face and numbness on left side of her face on an unknown date in Mar2021. Her injection side was on the left. Her doctor had her take an antibody test taken 12 days after, and it came back negative, she also stated the next time if patient would get it, she would get it in her right arm and patient was also concerned if she would get the second dose, it may be worse. Patient also wanted to know by when the patient would be developing the antibodies. On an unspecified date in Mar2021, the patient underwent lab tests and procedures which included SARS-CoV-2 antibody test which was negative. The outcome for both the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1482621
Sex: F
Age:
State: PA

Vax Date: 03/22/2021
Onset Date: 03/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer via Medical Information Team. A 56-year-old female consumer received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EP6955), via an unspecified route of administration, administered in left arm (left upper arm as reported) on 22Mar2021 at 9:30 am (at the age of 56-years-old) as dose 1, single for COVID-19 immunization (vaccine was being given out by military but is not a military facility). The patient medical history included blood pressure. Concomitant medications included Amlodipine for blood pressure which patient had been taking for 7 years. There was no history of all previously immunization and no additional vaccines administered on same date. No family medical history reported. Patient had been feeling dizzy for about a month prior to the first dose. On 23Mar2021 (very next day of vaccination), patient diagnosed with Covid and experienced fever, chills, and feeling cold on an unspecified date in Mar2021. Patient stated that she had a doctor appointment and went to the ear, nose, throat doctor the next day and she was sent for further testing for a COVID-19 test and results came back positive. Patient attributed events to getting the vaccine, but then had tested positive. After testing Positive for COVID-19, the patient had quarantine for a couple of weeks, 10-14 days. The events were Non-serious. Patient was due to have the 2nd vaccine on 12Apr2021 and was asking if she should reschedule as she would be out of quarantine by then. Patient stated that she does not even know if the first one was effective; and wants to know if she needs to start over and was asking if ok to get the second shot or she should wait. Patient stated that she was curious and that this was terrible. Patient asked if first one affected (because tested positive for COVID), was it considered effective or do she have to restart over again. The patient underwent lab tests which included SARS-CoV-2 Test: Positive (COVID-19) on 23Mar2021. Patient stated was given no other treatment tests: exam by ear, nose, throat doctor, nothing significant. The outcome of the events was unknown. It was reported that there was a product complaint with description of complaint: Test result positive for COVID-19 after receiving first dose COVID-19 Vaccine. Description of complaint: Patient again described the entire events in the complaint description. And additional information reported was: Product strength and count size dispensed: unknown; Additional lot numbers: unknown; There was no sample of the product available to be returned, if requested. It was unknown if the packaging was sealed and intact. Follow-up attempts completed. No further information expected.

Other Meds: AMLODIPINE

Current Illness:

ID: 1482622
Sex: F
Age:
State: PA

Vax Date: 03/24/2021
Onset Date: 03/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A female patient of 63-years-old received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in left upper arm on 24Mar2021 (at the age of 63-years-old) (Batch/Lot number as ER8730) at DOSE 1, SINGLE for COVID-19 immunization. Medical history includes asthma, migraine, vertigo. Concomitant medications include XOLAIR (100mg every 14 day) for asthma and her most recent asthma injection was on 19Mar2021. She had been getting the injections for 5 plus years maybe 8 years. She felt different felt like she was unwell or tired (on 24Mar2021). She stated this started within 15 minutes to half hour and was still ongoing. She stated this had improved. She stated fever started 4 hours after shot might be 3 hours and this was not still going on but at night she was having a fever (on 24Mar2021) when she was trying to sleep as she wakes up all sweated and her temperature has risen to 99 to 100. Sh stated her temperature was normal during the day then when she went to bed the fever starts to come. She stated this had improved since the fever was constant and now it was just at night. She stated nausea (24Mar2021) started about hour in a half after receiving her shot and was still ongoing and this had improved. She stated ringing in ears started 3 hours after the vaccine (24Mar2021) and was still ongoing. She stated the ringing has improved as it has gotten less loud. She stated the first three days she had a crazy amount of phlegm and coughing a lot (24Mar2021). She stated this started about 8 or 9 hours after the shot and was ongoing and this had improved. Chills and cold started 8 or 9 hours (24Mar2021) after the vaccine and stopped about the fourth day after the shot and she has recovered completely. On an unspecified date in Mar2021, coughing started three days after the vaccine and stopped around the fourth day. She stated she had recovered completely. On an unspecified date in Mar2021, tickle in back of throat started three days after the vaccine and she felt a tickle every once in a while in the back of her throat and this had improved. She stated she does have vertigo but it was almost like the vaccine kicked her vertigo up a few notches. She stated if she turned real quick or sits up in bed or turns over in bed she got dizzy. She stated she knew she had vertigo but the vaccine kicked it up few notches. She stated this started probably the evening she received the shot and was still ongoing. She stated this had persisted and was about the same. Rapid heartbeat started the day after the vaccine so on the second day within 24 hours of the vaccine she had a rapid heartbeat which was not all the time it was only when she exerts herself in the least little bit like walking to the bathroom and back to her chair and her heart was not pounding but it was like she was taking steroids and her heart was racing up a little or like the feeling when you drink too much coffee and get jittery. She stated if she sits still her heartbeat calms down but it does take a while. She stated this even happens when she was laying in bed still. She stated it was ongoing and has worsened. In treatment, there was no just been drinking a lot of water. Caller stated she got migraines and these symptoms were nothing and she did not need anything for the symptoms since she just weathers through her headaches. Caller stated she forgot this diarrhea. Caller stated this started 2.5 to 3 hours after the vaccine and cleared up within a couple of days. Caller stated she has recovered completely. AE did not require a visit to emergency room and physician office. The outcome of event Chills and cold, coughing, diarrhea was recovered on an unspecified date in Mar2021, outcome of event dizziness, rapid heartbeat was not recovered, and outcome of other events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: XOLAIR

Current Illness:

ID: 1482623
Sex: F
Age:
State: MN

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tingling lips; Tingling tongue; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8727) via an unspecified route of administration in the arm left on 30Mar2021 at 14:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive other medications within two weeks of vaccination. The patient had no allergies to food, drug or any other medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 16:00, the patient experienced tingling lips and tingling tongue. No therapeutic measures were taken as the result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tingling lips and tingling tongue was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482624
Sex: F
Age:
State: MD

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: joint pain; Knee pain; Pain in elbow; Shoulder pain; Hand pain; Tachycardia; Tingling sensation in back, under arms, shoulder blade.; This is a spontaneous report from a contactable consumer. A 63-year-old non-pregnant female patient received an unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8732), via an unspecified route of administration on the left arm on 27Mar2021 (at the age 0f 63-year-old) at 14:00, as a single dose for COVID-19 immunisation. Medical history of the patient included autonomic instability, asthma, type 2, ehler -danlos and also allergic to codeine, talwin, cipro, ceftin, penicillin, sulfa, latex, dairy, poison ivy and sumac. Concomitant medications included sertraline (MANUFACTURER UNKNOWN), tramadol (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), and co-codamol (MANUFACTURER UNKNOWN). The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was not diagnosed with COVID-19 was unknown. Since vaccination, the patient had not tested for COVID-19. On 27Mar2021 at 20:00, the patient experienced joint pain originally only at the shoulder on injection side, over 48 hours it got spread to knees, elbows, shoulders and hands/thumbs tachycardia within 24 hours. The patient also experienced slight itchiness and tingling/burning sensation on back, underarm, bicep, trap and shoulder blades. The patient had received tylenol (MANUFACTURER UNKNOWN), NSAID (MANUFACTURER UNKNOWN), BENADRYL, atenolol (MANUFACTURER UNKNOWN) as treatment for the adverse events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events joint, knee, elbow shoulders and hands pain with burning and itching sensation on back, underarms, bicep, trap and shoulder blades was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: ATENOLOL; SYNTHROID; SINGULAIR

Current Illness:

ID: 1482625
Sex: F
Age:
State: FL

Vax Date: 03/27/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 14:00 (at the age of 34-years-old) as a single dose for COVID-19 immunization. Medical history and allergic history to medications, food, or other products were reported as no. Concomitant medications included cetirizine hydrochloride (ZYRTEC), fluticasone propionate (FLONASE) and ibuprofen (MANUFACTURER UNKNOWN); all for unknown indication from an unspecified date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 01770605) via an unspecified route of administration in the left arm on 06Mar2021 at 14:00 (at the age of 34-years-old) as a single dose for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 02:00, 36 hours after receiving second dose the patient experienced arm swollen at injection site and swelling was the size of an egg. On 29Mar2021 at 14:00, 48 hours after receiving second dose, patient lower lip swelled up and 6 hours later the top lip started swelling up. Lip swelling started going down 24 hours after the start of each area. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events vaccination site swelling and lip swelling were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Zyrtec; IBUPROFEN; Flonase

Current Illness:

ID: 1482626
Sex: F
Age:
State:

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: slight pain/pinching sensation near lymph-nodes on armpit of injection arm; Stiffness/soreness on arm near injection; Stiffness/soreness on arm near injection; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 12:45 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included norethisterone acetate; ferrous fumarate; ethinylestradiol (JUNEL FE) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021, the patient experienced stiffness/soreness on arm near injection. On 29Mar2021, two days after injection, the patient experienced slight pain/pinching sensation near lymph-nodes in the armpit of injected arm. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent lab test on 30Mar2021 which included COVID test and the test result was pending. The patient did not receive any treatment for the events muscle stiffness, vaccination site pain and lymph node pain. The clinical outcomes of the events muscle stiffness, vaccination site pain and lymph node pain were recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: JUNEL FE

Current Illness:

ID: 1482627
Sex: F
Age:
State: AZ

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: low grade fever; fatigue; Injection site sore; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er8732) via an unspecified route of administration in the left arm on 28Mar2021 at 19:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6205) via an unspecified route of administration in the left arm on 07Mar2021 at 19:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient did not undergo a COVID-19 test. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Following day of vaccination on 29Mar2021 at 00:00, the patient experienced low grade fever, fatigue and injection site sore. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events low grade fever, fatigue and injection site sore. The clinical outcomes of the events low grade fever, fatigue and injection site sore were recovering at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1482628
Sex: F
Age:
State: AZ

Vax Date: 03/16/2021
Onset Date: 03/23/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: extreme fatigue; body pain/ internal organ pain to the point of doubling over; slight fever; severe headache; weird skin sensations; nausea; diarrhea; painful left arm; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 16Mar2021 at 12:15 (at the age of 71-years-old), as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa drugs. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN) 5 mg, for an unknown indication from unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, patient had not been tested for COVID-19. On 23Mar2021 at 12:00 (7 days after the second vaccination), the patient experienced extreme fatigue, body pain, internal organ pain to the point of doubling over, slight fever, severe headache, weird skin sensations, nausea, diarrhea and very painful left arm. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extreme fatigue, body pain, internal organ pain to the point of doubling over, slight fever, severe headache, weird skin sensations, nausea, diarrhea and very painful left arm were recovered on an unspecified date in Mar2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ROSUVASTATIN

Current Illness:

ID: 1482629
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lip; Brain fog; Headache; Arm pain; This is a spontaneous report from a non-contactable consumer, the patient. A 20-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if the patient was diagnosed with COVID-19 . Since the vaccination, the patient had not been tested for COVID-19. On an unknown date the patient experienced headache, swollen lip, brain fog and arm pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of headache, swollen lip, brain fog and arm pain were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482630
Sex: M
Age:
State: LA

Vax Date: 03/19/2021
Onset Date: 03/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High blood pressure/Patient reported that his blood pressure the other day was 224/124; migraine; headache; Anxiety level is really high; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 19Mar2021 (at the age of 73 year) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller wants to know if the use of Braftovi-Mektovi could cause high blood pressure, he has been taking the combination therapy for almost two years. Three nights ago, he had a "serious problem" with his blood pressure on 26Mar2021 and had to be sent to the emergency room, he cannot get in contact with his doctor because of the holidays. He is also reporting that 2 weeks ago he took the Pfizer Covid-19 vaccine manufactured by Pfizer and developed migraine and severe headache on 26Mar2021 for over a week, he is scheduled to receive the second dose of the vaccine on Friday. He is also having a scan next Wednesday. Patient is currently taking 4 different medications for his hypertension (5 pills per day). Caller mentioned that he might suspend his medication for the weekend until he sees his physician. Call was attempted to get transferred, but lines were too busy, caller was not able to hold on the line as he was not feeling very well, he accepted to get contacted back. Patient received the first dose of the vaccine two weeks ago and developed headaches and migraine, he is currently experiencing high blood pressure issues and is taking 5 different medications for that, he has also been taking Braftovi-Mektovi for 2 years. He is appointed to receive the second dose of the vaccine next Friday and wants to know if he should receive it. Patient reported that he has been experiencing really high blood pressure. Patient stated that he had to go to the emergency room the other night and may have to go again tonight. Patient reported that his blood pressure the other day was 224/124. Patient stated that he is on five different blood pressure medications. Patient stated that he took the Pfizer Covid vaccine two weeks ago and had migraines. Patient stated that his high blood pressure started around this time as well. Patient stated that his anxiety level is really high on Mar2021. I'm in a situation problem here now. I'm taking two Pfizer products here Braftovi and Mektovi (Intent: History) I don't know if you are familiar with these two. It's cancer chemotherapy, he has a diagnosis of Hypertension and takes blood pressure medication. Caller received his first Pfizer Covid 19 Vaccine on 19Mar2021. One week later he experienced elevated blood pressure & headache. Caller asking if he should take the second Pfizer Covid 19 Vaccine due to his experience with the first one. He plays with a band and will be traveling out of the country soon. He needs proof of receiving both vaccines. This case assessed as serious. The patient underwent lab tests and procedures which included blood pressure measurement: 224/124 on unspecified date. Patient visited to emergency room for the event High blood pressure. Therapeutic measures were taken as a result of the event High blood pressure. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482631
Sex: F
Age:
State: FL

Vax Date: 03/21/2021
Onset Date: 03/22/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe pain in arm one weekafter.; chills within 16 hours of shot lasting 18 hours.; fever within 16 hours of shot lasting 18 hours.; severe muscle aches within 16 hours of shot lasting 18 hours.; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration in left arm on 21Mar2021 at 1200 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient medical history included allergic to codeine. Concomitant medications were not reported. The patient previously received a first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route and site of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had not been tested for COVID-19 since the vaccination. On 22Mar2021, at 1500, the patient experienced chills, fever and severe muscle aches within 16 hours of shot which lasted for 18 hours. The patient also experienced severe pain in arm after one week on 29Mar2021. The adverse event did not result in a doctor or other healthcare professional office/clinic visit. No treatment was received for the adverse events reported. The clinical outcome of the events chills, fever, muscle aches and pain in arm were recovering at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482632
Sex: M
Age:
State: PA

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Uncontrolled, elevated heart rate before sleep; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the left arm on 29Mar2021 at 09:45 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient's allergies were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 23:30, after 1.5 days of vaccination, the patient experienced uncontrolled, elevated heart rate before sleep. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measure was taken as a result of adverse event. The clinical outcome of the event was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482633
Sex: F
Age:
State: CA

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever 100.5; chills; aches; very mild headache; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 11:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Allergic history to medications, food, or other products was not reported. The concomitant medications included cyanocobalamin (B12), pyridoxine hydrochloride (VITAMIN B-6), tocopherol (VITAMIN E), ascorbic acid (VITAMIN C), phytomenadione (VITAMIN K), iron (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN) on unknown date for unspecified indication. The patient previously received first dose BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Mar2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 10:00, the patient experienced fever 100.5 (unspecified units), chills, aches, very mild headache. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever 100.5, chills, aches, very mild headache was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: B12; VITAMIN B-6; Vitamin e; Vitamin c; Vitamin k; IRON; MAGNESIUM; ZINC

Current Illness:

ID: 1482634
Sex: F
Age:
State: SC

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Blister appeared in mouth on the skin on the roof of mouth towards the back; Slight tightness in chest.; Fever (101); Muscle aches; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER2613), via an unspecified route of administration in the left arm on 24Mar2021 at 16:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history included anxiety. Concomitant medications included fluoxetine hydrochloride (PROZAC) 10mg and bupropion hydrochloride (WELLBUTRIN) 150mg SR. The patient experienced allergies to nickel, thimerosal, and other preservative found in soaps. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6205,), via an unspecified route of administration in the left arm on 02Mar2021 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 05:00, the patient experienced fever (101) (unspecified units) with muscle aches and extreme fatigue. The patient also reported that these events lasted roughly 24 hours. On 27Mar2021, then each day after the patient experienced slight fatigue that worsened towards the end of the day. A week later, on an unspecified date in Apr2021, the patient also experienced a blister that appeared in mouth on the skin on the roof of mouth towards the back. The patient had never experienced this before. On an unspecified date in Apr2021, the patient experienced slight tightness in the chest and some fatigue still. Therapeutic measures included intake of TYLENOL on 25Mar2021. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events fever and muscle aches were resolved on 26Mar2021. The clinical outcomes of the events fatigue, blister appeared in mouth and slight tightness in chest were resolving. No follow-up attempts are needed. No further information is expected.

Other Meds: PROZAC; WELLBUTRIN SR

Current Illness:

ID: 1482635
Sex: F
Age:
State:

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tiredness, severe insomnia, irregular menstrual cycle (6 days late and it's never late), sore arm for 2 days, headaches; Tiredness; Severe insomnia; Irregular menstrual cycle; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 25Mar2021 at 16:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 17:30, the patient experienced tiredness, severe insomnia, irregular menstrual cycle (6 days late and it's never late), sore arm for 2 days and headache .The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tiredness, severe insomnia, irregular menstrual cycle, sore arm and headaches was not recovered at the time of this report No follow-up attempts are needed. No further information is expected.

Other Meds: SPIRONOLACTONE

Current Illness:

ID: 1482636
Sex: F
Age:
State: WI

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Soreness in arm; Aches; Nausea; Headache; Lethargy; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in her left arm on 26Mar2021 at 10:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. No medical history and concomitant medications were reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration in her right arm on 05Mar2021 at 12:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 01:00, the patient experienced chills, soreness in arm, aches, nausea, headache and lethargy. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events chills, soreness in arm, aches, nausea, headache and lethargy was recovered on an unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482637
Sex: U
Age:
State: NE

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: loss taste; loss of smell; Runny nose and slight congestion; runny nose; Sore arm day of injection; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old patient of unknown gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6208) via an unspecified route of administration in the arm right on 18Mar2021 at 14:45 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive medication within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient underwent lab test on 26Mar2021 which included nasal swab test, blood test, PCR, rapid COVID test and COVID antibody test and all the test result was negative. On 18Mar2021 the patient experienced sore arm, on 23Mar2021 the patient experienced runny nose and congestion and on 26Mar2021 the patient experienced loss taste and loss of smell. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events sore arm, runny nose and congestion, loss taste and loss of smell was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482638
Sex: F
Age:
State: FL

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen glands on my neck and on the right side; Pain severe.; This is a spontaneous report from a contactable consumer, the patient. A 69-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, hypertension, depression, anxiety, stroke. The patient was allergic to iodine and shellfish. Concomitant medications included unspecified medications received within two weeks of vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN62003) via an unspecified route of administration in the left arm on 06Mar2021 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. On 13Feb2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. On an unknown date, the patient underwent unspecified blood test and the result was negative. Since having the vaccine, the patient had been tested for COVID-19. On 28Mar2021 at 04:00, the patient experienced swollen glands on the neck and on the right side of head the side where glands were swollen, the pain was severe, it hurt till the temple of head. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen glands on my neck and on the right side and severe pain were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482639
Sex: F
Age:
State: NM

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Severe headache; Fatigue; Vomiting 2x; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 27Mar2021 at 08:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 08:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included statin (MANUFACTURER UNKNOWN) and escitalopram oxalate (LEXAPRO). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 19:30, the patient experienced chills, severe headache, fatigue, nausea and vomiting 2x. Lasted about 36 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was taken for the reported events. The clinical outcome of the events chills, severe headache, fatigue, nausea and vomiting was resolved on an unspecified date in Mar2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LEXAPRO

Current Illness:

ID: 1482640
Sex: F
Age:
State: NY

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 29Mar2021 at 11:45 (at the age of 54-years-old) as a single dose for COVID-19 immunization. Medical history included hay fever. Concomitant medication included mometasone furoate (FLONASE) taken for unknown indication. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 08Mar2021 13:45 PM. Prior to vaccination, patient was not diagnosed with COVID-19 and not tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient experienced soreness at injection site, headache and mild nausea. Therapeutic measures taken were acetaminophen 500mg for the events. The clinical outcome of the events injection site pain, headache and nausea was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Flonase

Current Illness:

ID: 1482641
Sex: U
Age:
State: NJ

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lip swelling after 3 hours of vaccination; arm pain on the vaccination location; This is a spontaneous report from a non-contactable healthcare professional. A patient of unknown age and gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 17:15 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 19:00 the patient experienced lip swelling after 3 hours of vaccination and had arm pain on the vaccination location. Therapeutic measures were taken as a result of the event arm pain on the vaccination location and included treatment with tylenol but the arm pain did not get better. The clinical outcome of the events arm pain on the vaccination location and lip swelling were not resolved at the time of the report. No follow-up attempts are possible; information about lot number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm